ProteoValent Therapeutics
PrivateCompany Overview
ProteoValent Therapeutics operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. It was founded in 2022.
ProteoValent Therapeutics is a biotechnology company focused on the development of therapeutic platforms, including PARP1-targeting PROTACs for the treatment of various human diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProteoValent Therapeutics Comparables
Compare ProteoValent Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avilar Therapeutics | 81% | |
| Amphista Therapeutics | 79% | |
| Arvinas Inc | 77% |
For institutional investors. Book with your work email.
ProteoValent Therapeutics Funding Rounds
Historical fundraising activity
ProteoValent Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plaisance Capital Management | Seed |
ProteoValent Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProteoValent Therapeutics's valuation, stock price, and market status.
Is ProteoValent Therapeutics a public or private company?
ProteoValent Therapeutics is a private company.
What is the current stock price of ProteoValent Therapeutics?
ProteoValent Therapeutics is a private company, so its shares have no public market price. Caplight tracks ProteoValent Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProteoValent Therapeutics worth (valuation)?
Valuation information for ProteoValent Therapeutics is not publicly available.
Can I buy ProteoValent Therapeutics stock?
ProteoValent Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProteoValent Therapeutics's last funding round?
Funding round information for ProteoValent Therapeutics is not publicly available.
Who are the main investors in ProteoValent Therapeutics?
Key investors in ProteoValent Therapeutics include Plaisance Capital Management.
Will ProteoValent Therapeutics IPO soon?
No public IPO plans have been announced for ProteoValent Therapeutics.
How can I track ProteoValent Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ProteoValent Therapeutics's shares on secondary markets.